Real-time enrollment status for this c3 glomerulopathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:05 AM UTC
| NCT Number | NCT07029542 |
| Recruiting Status | Recruiting |
| Condition | C3 Glomerulopathy |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 19, 2025 (Jun 19, 2025) |
As of July 17, 2026: Clinical trial NCT07029542 is currently recruiting participants. This clinical trial study for c3 glomerulopathy is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07029542 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07029542 was last updated Jun 19, 2025 (June 19, 2025). HelloStudys verifies this status automatically.